✦ LIBER ✦

Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients

✍ Scribed by Spratt, Daniel E.; Zelefsky, Michael J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Counterpoint: Is there a need for supple

✍ Stone, Nelson N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Treatment of intermediate-risk prostate

✍ Javier F. Torres-Roca; Alan B. Cantor; Sonia Shukla; Michael E. Montejo; Jay Fri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB

HAROW: Is there a need for a radical cha

✍ Heike Schön; Lothar Weissbach; Dietrich Schnell; Nicole Ernstmann 📂 Article 📅 2009 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 74 KB

Is there a role for platinum chemotherap

✍ William K. Oh; Miah-Hiang Tay; Jiaoti Huang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

Undetectable thyroglobulin after total t

✍ Ibrahimpasic, Tihana; Nixon, Iain J.; Palmer, Frank L.; Whitcher, Monica M.; Tut 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 232 KB

The results of real-time brachytherapy f

✍ Nicola L. Dallas; Peter R. Malone; Adam Jones; Andrew J. Doggart; Kevin J. McCon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB